Brainbees Solutions reports financial results for quarter and half year ended September 30 2026

Brainbees Solutions Limited announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company reported total income of ₹8,007.73 million for the quarter and ₹15,246.26 million for the half year on a standalone basis. The results have been approved by the Board of Directors and reviewed by the statutory auditors.

Particulars Quarter ended September 30, 2026 (Unaudited) Half year ended September 30, 2026 (Unaudited)
Total income (Standalone) ₹8,007.73 million ₹15,246.26 million
Profit before tax (Standalone) ₹507.69 million ₹801.62 million
Profit for the period/year (Standalone) ₹391.95 million ₹607.83 million
Total income (Consolidated) ₹24,376.14 million ₹45,907.46 million
Profit before tax (Consolidated) ₹1,004.55 million ₹2,410.07 million
Loss for the period/year (Consolidated) ₹125.88 million ₹565.40 million

Financial Highlights

Brainbees Solutions Limited has announced its unaudited financial results for the period ending September 30, 2026. On a standalone basis, the company reported a total income of ₹8,007.73 million for the quarter ended September 30, 2026, a significant increase from the previous periods. For the half year ended September 30, 2026, the standalone total income stood at ₹15,246.26 million. Profit before tax for the quarter was ₹507.69 million, and for the half year, it was ₹801.62 million.

Consolidated figures show total income of ₹24,376.14 million for the quarter and ₹45,907.46 million for the half year. The consolidated results indicate a loss for the period/year of ₹125.88 million for the quarter and ₹565.40 million for the half year.

Auditor’s Review

The unaudited financial results have been reviewed by the statutory auditors, Walker Chandiok & Co LLP. The review report states that based on their review, nothing has come to their attention that causes them to believe that the accompanying statement contains any material misstatement. The results are prepared in accordance with Indian Accounting Standard 34, Interim Financial Reporting.

Other Disclosures

The company also disclosed its asset and liability position as of September 30, 2026. The financial statements indicate significant investments and operational activities across various segments. The Board of Directors approved these results in a meeting held on November 14, 2026.

Source: BSE

Previous Article

Samrat Pharmachem reports ₹44.11 lakh profit for Q2 FY27